Caspase-4: A Therapeutic Target for Peptic Ulcer Disease
ImmunoHorizons 4(10): 627-633
Article 2020 English
Authors
ZZ
Zbigniew Zasłona
EF
Ewelina Flis
CN
Ciara Nulty
Abstract
1 min read
Peptic ulcers are caused by the interaction between bacterial and host factors. This study demonstrates enhanced expression of caspase-4 in peptic ulcer patient biopsies, indicating that pyroptosis and noncanonical inflammasome activity may be processes involved in peptic ulcer disease. We show that primary murine macrophages infected with Helicobacter pylori upregulate caspase-11 (the ortholog of human caspase-4), activate caspase-1, and secrete IL-1β. We demonstrate that misoprostol (a stable PGE1 analogue) decreased IL-1β secretion and delayed lethality in vivo in a murine peritonitis model. PGE2 was shown to inhibit caspase-11–driven pyroptosis and IL-1β secretion in macrophages. Overall, we provide evidence for a pathological role of caspase-4/11 in peptic ulcer disease and propose that targeting caspase-4 or inhibiting pyroptosis may have therapeutic potential in the management of peptic ulcers.
Zbigniew Zasłona, Ewelina Flis, Mieszko M. Wilk, Richard G. Carroll, Eva M. Pålsson‐McDermott, Mark Hughes, Ciana Diskin, Kathy Banahan, Dylan G. Ryan, Alexander Hooftman, Alicja Misiak, Jay Kearney, Günter Lochnit, Wilhelm Bertrams, Timm Greulich, Bernd Schmeck, Oliver J. McElvaney, Kingston H. G. Mills, Ed C. Lavelle, Małgorzata Wygrecka, Emma M. Creagh, Luke O'neill
Katarzyna Oficjalska, Mathilde Raverdeau, Gabriella Aviello, Siobhan Wade, Ana Hickey, Katherine M. Sheehan, Sinéad C. Corr, Elaine W. Kay, Luke O'neill, Kingston H. G. Mills, Emma M. Creagh
Discussion(0)
No comments yet. Be the first to comment.